VANGUARD GROUP INC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for TG Therapeutics Inc (TGTX)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: TG Therapeutics Inc Common Stock
Symbol: TGTX
Shares outstanding: 156M shares
Disclosed Ownership: 15.6M shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Date filed: 1/8/2025, 11:29 AM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	10.01%	15.6M	0	267K	Ashley Grim	Head of Global Fund Administration